Browse by People

Davies, Geraint ORCID: 0000-0002-3819-490X, Boeree, Martin, Hermann, Dave and Hoelscher, Michael (2019) Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs. PLOS MEDICINE, 16 (7). e1002851-.

Stott, Katharine E ORCID: 0000-0001-7079-7957, Singh, Bhagteshwar ORCID: 0000-0002-9039-3674, Beadsworth, Mike BJ, Vaudrey, Kate, Khoo, Saye H ORCID: 0000-0002-2769-0967 and Davies, Geraint ORCID: 0000-0002-3819-490X (2016) Adequacy of Rifampin Absorption after Jejunostomy Tube Administration. PHARMACOTHERAPY, 36 (4). E23-E25.

Richardson, Marty ORCID: 0000-0002-7097-8704, Kirkham, Jamie ORCID: 0000-0003-2579-9325, Dwan, Kerry ORCID: 0000-0001-6918-1215, Sloan, Derek ORCID: 0000-0002-7888-5449, Davies, Geraint ORCID: 0000-0002-3819-490X and Jorgensen, Andrea ORCID: 0000-0002-6977-9337 (2019) Association of variants within the <i>GST</i> and other genes with anti-tubercular agents related toxicity: a systematic review and meta-analysis. bioRxiv.

Hu, Yanmin, Pertinez, Henry, Liu, Yingjun, Davies, Geraint ORCID: 0000-0002-3819-490X and Coates, Anthony (2019) Bedaquiline kills persistent Mycobacterium tuberculosis with no disease relapse: an in vivo model of a potential cure. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 74 (6). pp. 1627-1633.

Barr, DA ORCID: 0000-0002-2922-9381 (2018) Characterising HIV-associated Mycobacterium tuberculosis blood stream infection. PhD thesis, University of Liverpool.

Cohen, Danielle B, Mbendera, Kuzani, Maheswaran, Hendramoorthy ORCID: 0000-0002-7375-4845, Mukaka, Mavuto, Mangochi, Helen, Phiri, Linna, Madan, Jason, Davies, Geraint ORCID: 0000-0002-3819-490X, Corbett, Elizabeth and Squire, Bertel (2020) Delivery of long-term-injectable agents for TB by lay carers: pragmatic randomised trial. THORAX, 75 (1). pp. 64-71.

Collapse authors list.
Sibley, Laura, White, Andrew D, Sarfas, Charlotte, Gullick, Jennie, Gleeson, Fergus, Lanni, Faye, Clark, Simon, Rayner, Emma, Ferrer-Bazaga, Santiago, Ortega-Muro, Fatima et al (show 12 more authors) , Alameda, Laura, Rullas, Joaquin, Sousa, Veronica, Martinez, Marisa, Angulo-Barturen, Inigo, Garcia, Adolfo, Vaquero, Juan Jose, Pertinez, Henry E, Davies, Geraint ORCID: 0000-0002-3819-490X, Dennis, Mike, Williams, Ann and Sharpe, Sally (2022) Determination of the Pharmacokinetics and Pharmacodynamics of Isoniazid, Rifampicin, Pyrazinamide and Ethambutol in a Cross-Over Cynomolgus Macaque Model of Mycobacterium tuberculosis Infection. PHARMACEUTICS, 14 (12). 2666-.

Serra, Alessandra, Mozgunov, Pavel, Davies, Geraint ORCID: 0000-0002-3819-490X and Jaki, Thomas (2023) Determining the minimum duration of treatment in tuberculosis: An order restricted non-inferiority trial design. PHARMACEUTICAL STATISTICS, 22 (5). pp. 938-962.

Richardson, Marty ORCID: 0000-0002-7097-8704, Kirkham, Jamie ORCID: 0000-0003-2579-9325, Dwan, Kerry, Sloan, Derek, Davies, Geraint and Jorgensen, Andrea ORCID: 0000-0002-6977-9337 (2018) Development of reporting guidelines for pharmacogenetic studies to facilitate evidence synthesis. .

Collapse authors list.
Milstein, Meredith, Lecca, Leonid, Peloquin, Charles, Mitchison, Denis, Seung, Kwonjune, Pagano, Marcello, Coleman, David, Osso, Elna, Coit, Julia, Vargas Vasquez, Dante Elmo et al (show 5 more authors) , Sanchez Garavito, Epifanio, Calderon, Roger, Contreras, Carmen, Davies, Geraint ORCID: 0000-0002-3819-490X and Mitnick, Carole D (2016) Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial. BMC infectious diseases, 16 (1). p. 453.

Requena-Mendez, Ana, Davies, Geraint ORCID: 0000-0002-3819-490X, Waterhouse, David, Ardrey, Alison, Jave, Oswaldo, Llanet Lopez-Romero, Sonia, Ward, Stephen A and Moore, David AJ (2019) Intra-individual effects of food upon the pharmacokinetics of rifampicin and isoniazid. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 74 (2). pp. 416-424.

Hu, Yanmin, Pertinez, Henry, Ortega-Muro, Fatima, Alameda-Martin, Laura, Liu, Yingjun, Schipani, Alessandro, Davies, Geraint ORCID: 0000-0002-3819-490X and Coates, Anthony (2016) Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 60 (8). pp. 4778-4785.

Collapse authors list.
Millard, James ORCID: 0000-0001-6427-552X, Pertinez, Henry, Bonnett, Laura ORCID: 0000-0002-6981-9212, Hodel, Eva Maria ORCID: 0000-0001-5821-1685, Dartois, Veronique, Johnson, John L, Caws, Maxine, Tiberi, Simon, Bolhuis, Mathieu, Alffenaar, Jan-Willem C et al (show 2 more authors) , Davies, Geraint ORCID: 0000-0002-3819-490X and Sloan, Derek J (2018) Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 73 (7). pp. 1755-1762.

Collapse authors list.
Millard, james ORCID: 0000-0001-6427-552X, Pertinez, henry, Bonnett, LJ ORCID: 0000-0002-6981-9212, Hodel, eva ORCID: 0000-0001-5821-1685, Dartois, Veronique, Johnson, John L, Caws, Maxine, Tiberi, Simon, Bolhuis, Mathieu, Alffenaar, Jan-Willem C et al (show 2 more authors) , Davies, Geraint ORCID: 0000-0002-3819-490X and Sloan, Derek (2018) Linezolid pharmacokinetics in multidrug resistant tuberculosis (MDR TB): a systematic review, meta-analysis and Monte Carlo simulation. Journal of Antimicrobial Chemotherapy.

Liu, Yingjun, Pertinez, Henry, Ortega-Muro, Fatima, Alameda-Martin, Laura, Harrison, Thomas, Davies, Geraint ORCID: 0000-0002-3819-490X, Coates, Anthony and Hu, Yanmin (2018) Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteria. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 73 (3). pp. 724-731.

Sloan, Derek, Mwandumba, Henry, Garton, Natalie J, Khoo, Saye, Butterworth, Anthony E, Allain, Theresa J, Heyderman, Robert S, Corbett, Elizabeth L, Barer, Mike R and Davies, Geraint (2015) Pharmacodynamic Modeling of Bacillary Elimination Rates and Detection of Bacterial Lipid Bodies in Sputum to Predict and Understand Outcomes in Treatment of Pulmonary Tuberculosis. Clinical Infectious Diseases, 61 (01). 1 - 8.

Richardson, Marty ORCID: 0000-0002-7097-8704, Kirkham, Jamie J ORCID: 0000-0003-2579-9325, Dwan, Kerry M, Sloan, Derek J, Davies, Geraint ORCID: 0000-0002-3819-490X and Jorgensen, Andrea ORCID: 0000-0002-6977-9337 (2019) Protocol for the development of the STrengthening the Reporting Of Pharmacogenetic Studies (STROPS) guideline: checklist of items for reporting pharmacogenetic studies. BMJ OPEN, 9 (7). e030212-.

Hendon-Dunn, Charlotte L, Pertinez, Henry, Marriott, Alice AN, Hatch, Kim A, Allnutt, Jon C, Davies, Geraint and Bacon, Joanna (2019) Regrowth of <i>Mycobacterium</i> <i>tuberculosis</i> Populations Exposed to Antibiotic Combinations Is Due to the Presence of Isoniazid and Not Bacterial Growth Rate. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 63 (12). AAC.00570-AAC.00519.

Bonnett, Laura J ORCID: 0000-0002-6981-9212 and Davies, Geraint (2015) Reported outcomes in phase II studies of newly-diagnosed pulmonary tuberculosis. Trials, 16 (Suppl ). P7-P7.

Bonnett, Laura J ORCID: 0000-0002-6981-9212 and Davies, Geraint ORCID: 0000-0002-3819-490X (2015) Reported outcomes in phase II studies of newly-diagnosed pulmonary tuberculosis. TRIALS, 16.

Chaplin, Marty ORCID: 0000-0002-7097-8704, Kirkham, Jamie J ORCID: 0000-0003-2579-9325, Dwan, Kerry, Sloan, Derek J, Davies, Geraint ORCID: 0000-0002-3819-490X and Jorgensen, Andrea L ORCID: 0000-0002-6977-9337 (2020) STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline. PLOS MEDICINE, 17 (9). e1003344-.

Dickinson, Laura ORCID: 0000-0001-5557-9396, Jackson, Akil ORCID: 0000-0002-4574-544X, Garvey, L, Watson, Victoria, Khoo, Saye ORCID: 0000-0002-2769-0967, Boffito, M, Davies, Geraint ORCID: 0000-0002-3819-490X and Back, David (2012) Simultaneous population pharmacokinetic modelling of darunavir and ritonavir Once daily in HIV-infected patients: evaluation of lower ritonavir dose. Journal of the International AIDS Society, 15 (4).

Kamara, Rashidatu Fouad, Saunders, Matthew J, Sahr, Foday, Losa-Garcia, Juan E, Foray, Lynda, Davies, Geraint ORCID: 0000-0002-3819-490X and Wingfield, Tom ORCID: 0000-0001-8433-6887 (2022) Social and health factors associated with adverse treatment outcomes among people with multidrug-resistant tuberculosis in Sierra Leone: a national, retrospective cohort study. LANCET GLOBAL HEALTH, 10 (4). E543-E554.

Collapse authors list.
Sabiiti, Wilber, Azam, Khalide, Farmer, Eoghan Charles William, Kuchaka, Davis, Mtafya, Bariki, Bowness, Ruth, Oravcova, Katarina, Honeyborne, Isobella, Evangelopoulos, Dimitrios, McHugh, Timothy Daniel et al (show 18 more authors) , Khosa, Celso, Rachow, Andrea, Heinrich, Norbert, Kampira, Elizabeth, Davies, Geraint ORCID: 0000-0002-3819-490X, Bhatt, Nilesh, Ntinginya, Elias N, Viegas, Sofia, Jani, Ilesh, Kamdolozi, Mercy, Mdolo, Aaron, Khonga, Margaret, Boeree, Martin J, Phillips, Patrick PJ, Sloan, Derek, Hoelscher, Michael, Kibiki, Gibson and Gillespie, Stephen H (2020) Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis Molecular Bacterial Load Assay. THORAX, 75 (7). pp. 606-608.

Ndhlovu, VS (2019) Understanding molecular mechanisms of Mycobacterium tuberculosis persistence. PhD thesis, University of Liverpool.

Richardson, Marty ORCID: 0000-0002-7097-8704, Kirkham, Jamie ORCID: 0000-0003-2579-9325, Dwan, Kerry, Sloan, Derek J, Davies, Geraint ORCID: 0000-0002-3819-490X and Jorgensen, Andrea L ORCID: 0000-0002-6977-9337 (2018) <i>CYP</i> genetic variants and toxicity related to anti-tubercular agents: a systematic review and meta-analysis. SYSTEMATIC REVIEWS, 7 (1). 204-.

Collapse authors list.
Lanni, Faye, Burton, Neil, Harris, Debbie, Fotheringham, Susan, Clark, Simon, Skinner, Oliver, Wiblin, Nathan, Dennis, Mike, Armstrong, Stuart, Davies, Geraint ORCID: 0000-0002-3819-490X et al (show 1 more authors) and Williams, Ann (2021) The potential of microdialysis to estimate rifampicin concentrations in the lung of guinea pigs. PLOS ONE, 16 (1). e0245922-.

Millard, James ORCID: 0000-0001-6427-552X (2023) A study of the optimisation of tuberculosis therapy. PhD thesis, University of Liverpool.